ProBioTx-11
Natural health product licensed in Canada
- Other names
- Sangster's
- Licence holder
- 1123573 BC Ltd.
- NPN or DIN-HM
- 80038765
- Status
- Active licence
- Licence date
- 16 January 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 3-(1-3,1-4)-bêta-D-glucan 3(4)-glucanohydrolase Source : Trichoderma longibrachiatum | 1.03 mg | Not calculated |
| 3-(1-3,1-4)-bêta-D-glucan 3(4)-glucanohydrolase Source : Trichoderma longibrachiatum | 3.6 FCC BGU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma longibrachiatum | 2.48 mg | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma longibrachiatum | 99 FCC CU | Not calculated |
| Fructooligosaccharides Source : Cichorium intybus - racine | 100 mg | Not calculated |
| Lactobacillus plantarum Source : Lp-15 | 500 Millions d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : ATCC 15707 | 250 Millions d'UFC | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger | 2.8 mg | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger | 55 FCC LU | Not calculated |
| Lactobacillus delbrueckii subsp. bulgaricus Source : LB-64 | 250 Millions d'UFC | Not calculated |
| Poly(1-4-a-D-galacturonide)glycanohydrolase Source : Aspergillus niger | 2.67 mg | Not calculated |
| Poly(1-4-a-D-galacturonide)glycanohydrolase Source : Aspergillus niger | 4 Endo-PG | Not calculated |
| Bifidobacterium longum subsp. infantis | 500 Millions d'UFC | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae | 2 mg | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae | 40 FCC LU | Not calculated |
Non-medicinal ingredients
Gélatine, Maltodextrine, Mineral oil
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Probiotics that temporarily modify gut flora.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80038765
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.